'Macrovascular complications' presentation slideshows

Management of DM and its complications

840 views • 65 slides

TREAT TO TARGET IN DIABETES: An Alternative pathway

TREAT TO TARGET IN DIABETES: An Alternative pathway. ASSOC PROF DR AZIZ AL-SAFI ISMAIL Universiti Sains Malaysia Kubang Kerian, Kelantan. Malaysia Total populations 26 million Lifespan 69.6 yrs Male, 74.5 yrs Female. Main cause of death in hospital Heart disease Septicaemia Stroke

431 views • 28 slides

RISK FACTOR PROFILE AND CONTROL IN TYPE 2 DIABETES AT KNH

RISK FACTOR PROFILE AND CONTROL IN TYPE 2 DIABETES AT KNH. What does it mean to our patients? Presenter: CF Otieno Affiliation : Department of Clinical Medicine and Therapeutics,UoN & KNH-Medicine. TYPE 2 DIABETES. Progressive disease Well characterized . . . But-poorly controlled

214 views • 13 slides

HOME

HOME. Micro- and macrovascular complications: 31% with metformin vs. 28% with placebo Macrovascular complications: 15% vs. 18%, respectively Microvascular complications: 17% vs. 15% (adjusted p value = 0.43), respectively.

153 views • 1 slides